NOTICE -- Labnodes will be unavailable On Saturday evening to Sunday morning for scheduled maintenance. We appreciate your patience and we ask that you let us know if you experience any issues.
NOTICE: Labnodes now supports vumc.org email addresses. If your email changed, please update your profile today.

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Altered intrathalamic GABAA neurotransmission in a mouse model of a human genetic absence epilepsy syndrome. Zhou C, Ding L, Deel ME, Ferrick EA, Emeson RB, Gallagher MJ (2015) Neurobiol Dis : 407-17
    › Primary publication · 25447232 (PubMed) · PMC4418938 (PubMed Central)
  2. Reovirus-mediated induction of ADAR1 (p150) minimally alters RNA editing patterns in discrete brain regions. Hood JL, Morabito MV, Martinez CR, Gilbert JA, Ferrick EA, Ayers GD, Chappell JD, Dermody TS, Emeson RB (2014) Mol Cell Neurosci : 97-109
    › Primary publication · 24906008 (PubMed) · PMC4134954 (PubMed Central)
  3. One hundred million adenosine-to-inosine RNA editing sites: hearing through the noise. Ulbricht RJ, Emeson RB (2014) Bioessays 36(8): 730-5
    › Primary publication · 24889193 (PubMed) · PMC4359916 (PubMed Central)
  4. Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence. Anastasio NC, Stutz SJ, Fox RG, Sears RM, Emeson RB, DiLeone RJ, O'Neil RT, Fink LH, Li D, Green TA, Moeller FG, Cunningham KA (2014) Neuropsychopharmacology 39(2): 370-82
    › Primary publication · 23939424 (PubMed) · PMC3970795 (PubMed Central)
  5. Quantitative analysis of 5HT(2C) receptor RNA editing patterns in psychiatric disorders. O'Neil RT, Emeson RB (2012) Neurobiol Dis 45(1): 8-13
    › Primary publication · 21914481 (PubMed) · PMC3225646 (PubMed Central)
  6. Editing of neurotransmitter receptor and ion channel RNAs in the nervous system. Hood JL, Emeson RB (2012) Curr Top Microbiol Immunol : 61-90
    › Primary publication · 21796513 (PubMed) · PMC4109139 (PubMed Central)
  7. The solution structure of the ADAR2 dsRBM-RNA complex reveals a sequence-specific readout of the minor groove. Stefl R, Oberstrass FC, Hood JL, Jourdan M, Zimmermann M, Skrisovska L, Maris C, Peng L, Hofr C, Emeson RB, Allain FH (2010) Cell 143(2): 225-37
    › Primary publication · 20946981 (PubMed) · PMC2956598 (PubMed Central)
  8. Impact of RNA editing on functions of the serotonin 2C receptor in vivo. Olaghere da Silva UB, Morabito MV, Canal CE, Airey DC, Emeson RB, Sanders-Bush E (2010) Front Neurosci : 26
    › Primary publication · 20582266 (PubMed) · PMC2858556 (PubMed Central)
  9. Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Morabito MV, Abbas AI, Hood JL, Kesterson RA, Jacobs MM, Kump DS, Hachey DL, Roth BL, Emeson RB (2010) Neurobiol Dis 39(2): 169-80
    › Primary publication · 20394819 (PubMed) · PMC2906772 (PubMed Central)
  10. High-throughput multiplexed transcript analysis yields enhanced resolution of 5-hydroxytryptamine 2C receptor mRNA editing profiles. Morabito MV, Ulbricht RJ, O'Neil RT, Airey DC, Lu P, Zhang B, Wang L, Emeson RB (2010) Mol Pharmacol 77(6): 895-902
    › Primary publication · 20181818 (PubMed) · PMC2879922 (PubMed Central)
  11. An innovative real-time PCR method to measure changes in RNA editing of the serotonin 2C receptor (5-HT(2C)R) in brain. Lanfranco MF, Seitz PK, Morabito MV, Emeson RB, Sanders-Bush E, Cunningham KA (2009) J Neurosci Methods 179(2): 247-57
    › Primary publication · 19428534 (PubMed) · PMC3794365 (PubMed Central)
  12. ADAR1 and ADAR2 expression and editing activity during forebrain development. Jacobs MM, Fogg RL, Emeson RB, Stanwood GD (2009) Dev Neurosci 31(3): 223-37
    › Primary publication · 19325227 (PubMed) · PMC2692045 (PubMed Central)
  13. RNA editing as a therapeutic target for CNS disorders. Morabito MV, Emeson RB (2009) Neuropsychopharmacology 34(1): 246
    › Primary publication · 19079070 (PubMed)
  14. Developmental modulation of GABA(A) receptor function by RNA editing. Rula EY, Lagrange AH, Jacobs MM, Hu N, Macdonald RL, Emeson RB (2008) J Neurosci 28(24): 6196-201
    › Primary publication · 18550761 (PubMed) · PMC2746000 (PubMed Central)
  15. The role of calcitonin and alpha-calcitonin gene-related peptide in bone formation. Huebner AK, Keller J, Catala-Lehnen P, Perkovic S, Streichert T, Emeson RB, Amling M, Schinke T (2008) Arch Biochem Biophys 473(2): 210-7
    › Primary publication · 18307972 (PubMed)
  16. Mouse models to elucidate the functional roles of adenosine-to-inosine editing. Rula EY, Emeson RB (2007) Methods Enzymol : 333-67
    › Primary publication · 17662849 (PubMed)
  17. Hyperphagia-mediated obesity in transgenic mice misexpressing the RNA-editing enzyme ADAR2. Singh M, Kesterson RA, Jacobs MM, Joers JM, Gore JC, Emeson RB (2007) J Biol Chem 282(31): 22448-59
    › Primary publication · 17567573 (PubMed)
  18. Protective roles of alpha-calcitonin and beta-calcitonin gene-related peptide in spontaneous and experimentally induced colitis. Thompson BJ, Washington MK, Kurre U, Singh M, Rula EY, Emeson RB (2008) Dig Dis Sci 53(1): 229-41
    › Primary publication · 17530400 (PubMed)
  19. Calcitonin deficiency in mice progressively results in high bone turnover. Huebner AK, Schinke T, Priemel M, Schilling S, Schilling AF, Emeson RB, Rueger JM, Amling M (2006) J Bone Miner Res 21(12): 1924-34
    › Primary publication · 17002587 (PubMed)
  20. Substrate-dependent contribution of double-stranded RNA-binding motifs to ADAR2 function. Xu M, Wells KS, Emeson RB (2006) Mol Biol Cell 17(7): 3211-20
    › Primary publication · 16672376 (PubMed) · PMC1552048 (PubMed Central)
  21. RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA, Emeson RB, Sanders-Bush E (2001) Neuropsychopharmacology 24(5): 478-91
    › Primary publication · 11282248 (PubMed)
  22. A signal sequence is sufficient for green fluorescent protein to be routed to regulated secretory granules. El Meskini R, Jin L, Marx R, Bruzzaniti A, Lee J, Emeson R, Mains R (2001) Endocrinology 142(2): 864-73
    › Primary publication · 11159860 (PubMed)
  23. Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development. Lu JT, Son YJ, Lee J, Jetton TL, Shiota M, Moscoso L, Niswender KD, Loewy AD, Magnuson MA, Sanes JR, Emeson RB (1999) Mol Cell Neurosci 14(2): 99-120
    › Primary publication · 10532808 (PubMed)
  24. Regulation of alternative splicing by RNA editing. Rueter SM, Dawson TR, Emeson RB (1999) Nature 399(6731): 75-80
    › Primary publication · 10331393 (PubMed)
  25. Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. Canton H, Emeson RB, Barker EL, Backstrom JR, Lu JT, Chang MS, Sanders-Bush E (1996) Mol Pharmacol 50(4): 799-807
    › Primary publication · 8863824 (PubMed)
  26. RNA editing. Simpson L, Emeson RB (1996) Annu Rev Neurosci : 27-52
    › Primary publication · 8833435 (PubMed)
  27. Control of calcitonin/calcitonin gene-related peptide pre-mRNA processing by constitutive intron and exon elements. Yeakley JM, Hedjran F, Morfin JP, Merillat N, Rosenfeld MG, Emeson RB (1993) Mol Cell Biol 13(10): 5999-6011
    › Primary publication · 8413203 (PubMed) · PMC364659 (PubMed Central)
  28. Alternative splicing generates multiple isoforms of a rabbit prostaglandin E2 receptor. Breyer RM, Emeson RB, Tarng JL, Breyer MD, Davis LS, Abromson RM, Ferrenbach SM (1994) J Biol Chem 269(8): 6163-9
    › Primary publication · 8119961 (PubMed)
  29. Glutamate receptor RNA editing in vitro by enzymatic conversion of adenosine to inosine. Rueter SM, Burns CM, Coode SA, Mookherjee P, Emeson RB (1995) Science 267(5203): 1491-4
    › Primary publication · 7878468 (PubMed)
  30. Hypothalamic peptidyl-glycine alpha-amidating monooxygenase: preliminary characterization. Emeson RB (1984) J Neurosci 4(10): 2604-13
    › Primary publication · 6491725 (PubMed)
  31. Characterization of pro-ACTH/endorphin-derived peptides in rat hypothalamus. Emeson RB, Eipper BA (1986) J Neurosci 6(3): 837-49
    › Primary publication · 3007691 (PubMed)
  32. Alternative production of calcitonin and CGRP mRNA is regulated at the calcitonin-specific splice acceptor. Emeson RB, Hedjran F, Yeakley JM, Guise JW, Rosenfeld MG (1989) Nature 341(6237): 76-80
    › Primary publication · 2788825 (PubMed)
  33. Calcitonin gene-related peptide: a neuropeptide generated as a consequence of tissue-specific, developmentally regulated alternative RNA processing events. Rosenfeld MG, Emeson RB, Yeakley JM, Merillat N, Hedjran F, Lenz J, Delsert C (1992) Ann N Y Acad Sci : 1-17
    › Primary publication · 1637077 (PubMed)
  34. Posttranscriptional regulation of calcitonin/CGRP gene expression. Emeson RB, Yeakley JM, Hedjran F, Merillat N, Lenz HJ, Rosenfeld MG (1992) Ann N Y Acad Sci : 18-35
    › Primary publication · 1386208 (PubMed)